Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether an early rehabilitation program for immediate liver transplant patients is safe and effective in preventing critical care illness and intensive care unit acquired weakness.


Clinical Trial Description

Patients with liver transplantation (LT) have poor general condition before surgery and require ICU care for a certain period. For those patients, the side effects of ICU care such as intensive care unit-acquired weakness (ICU-AW), critical illness polyneuropathy (CIP) are well known. Therefore, we access the safety and efficacy of early rehabilitation program (ERP) in liver transplant recipients.

Patients were retrospectively selected for the Pre-ERP group (2014.05-2014.10) and for the Post-ERP group (2015.10-2016.03). During the period of 6 months, 136 patients and 100 patients underwent LT, and 65, 62 patients were enrolled after exclusion. Forty patients from the each group were compared after propensity score matching (PSM). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03529656
Study type Interventional
Source Asan Medical Center
Contact
Status Completed
Phase N/A
Start date October 1, 2014
Completion date March 31, 2017

See also
  Status Clinical Trial Phase
Completed NCT03055949 - Safety and Efficacy of an Early Rehabilitation Program in Surgical Intensive Care Unit N/A
Withdrawn NCT03071354 - Improving Muscle Function in Nutritionally at Risk, Elderly Patients N/A